 , Antineoplastic Agents , Antineoplastic Agents, Phytogenic , Antineoplastic and Immunomodulating Agents , BCRP/ABCG2 Substrates , Carbohydrates , Cardiotoxic antineoplastic agents , Cytochrome P-450 CYP1A2 Substrates , Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2E1 Substrates , Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A Inducers , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inducers , Cytochrome P-450 CYP3A4 Inducers (strength unknown) , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inducers , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Enzyme Inhibitors , Glucosides , Glycosides , Immunosuppressive Agents , Myelosuppressive Agents , Naphthalenes , Narrow Therapeutic Index Drugs , P-glycoprotein inhibitors , P-glycoprotein substrates , P-glycoprotein substrates with a Narrow Therapeutic Index , Podophyllotoxin , Podophyllotoxin Derivatives , Tetrahydronaphthalenes , Topoisomerase II Inhibitors , Topoisomerase Inhibitors , UGT1A1 Substrates , UGT1A1 Substrates with a Narrow Therapeutic Index